Cargando…

Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area

Detalles Bibliográficos
Autores principales: Cortese, Andrea, Vita, Giuseppe, Obici, Laura, Sabatelli, Marco, Fabrizi, Gian Maria, Schenone, Angelo, Merlini, Giampaolo, Pareyson, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642123/
http://dx.doi.org/10.1186/1750-1172-10-S1-P6
_version_ 1782400310554132480
author Cortese, Andrea
Vita, Giuseppe
Obici, Laura
Sabatelli, Marco
Fabrizi, Gian Maria
Schenone, Angelo
Merlini, Giampaolo
Pareyson, Davide
author_facet Cortese, Andrea
Vita, Giuseppe
Obici, Laura
Sabatelli, Marco
Fabrizi, Gian Maria
Schenone, Angelo
Merlini, Giampaolo
Pareyson, Davide
author_sort Cortese, Andrea
collection PubMed
description
format Online
Article
Text
id pubmed-4642123
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46421232015-11-19 Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area Cortese, Andrea Vita, Giuseppe Obici, Laura Sabatelli, Marco Fabrizi, Gian Maria Schenone, Angelo Merlini, Giampaolo Pareyson, Davide Orphanet J Rare Dis Poster Presentation BioMed Central 2015-11-02 /pmc/articles/PMC4642123/ http://dx.doi.org/10.1186/1750-1172-10-S1-P6 Text en Copyright © 2015 Cortese et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Cortese, Andrea
Vita, Giuseppe
Obici, Laura
Sabatelli, Marco
Fabrizi, Gian Maria
Schenone, Angelo
Merlini, Giampaolo
Pareyson, Davide
Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
title Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
title_full Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
title_fullStr Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
title_full_unstemmed Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
title_short Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
title_sort monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy: a 3-year longitudinal multicenter study in a non-endemic area
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642123/
http://dx.doi.org/10.1186/1750-1172-10-S1-P6
work_keys_str_mv AT corteseandrea monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT vitagiuseppe monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT obicilaura monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT sabatellimarco monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT fabrizigianmaria monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT schenoneangelo monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT merlinigiampaolo monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea
AT pareysondavide monitoringsafetyandeffectivenessoftafamidisintransthyretinamyloidosisinitalya3yearlongitudinalmulticenterstudyinanonendemicarea